Skip to content

Mindfulness Based Smoking Cessation Program

Feasibility, Acceptability and Effectiveness of Modified Mindfulness Based Stress Reduction (MBSR) for Smoking Cessation in Cancer Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02795312
Enrollment
18
Registered
2016-06-10
Start date
2016-07-31
Completion date
2018-03-31
Last updated
2020-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Smoking Cessation

Keywords

Cigarette Smoking

Brief summary

This is a study designed to mindfulness based stress reduction (MBSR) training program to assess feasibility and acceptability of the intervention. Participants will participate in a 9-week training program and complete pre-and post-questionnaires. Participants will have the option of participating in a follow-up focus group.

Detailed description

The investigators will introduce a mindfulness based stress reduction (MBSR) training program at Boston Medical Center's oncology clinic to promote engagement of low-income and minority smokers with cancer in smoking cessation. This training will follow an adapted MBSR curriculum designed by and for Boston Medical Center patients with chronic pain in the Integrated Medical Group Visit research program in Family Medicine. The investigators will tailor this adapted MBSR curriculum to address smoking cessation. To test the feasibility and acceptability of our intervention, the investigators will pilot test it with 30 patients over the course of three MBSR training programs (each cohort is 9 weeks). The investigators will acquire feasibility data (number of inquiries, number of sessions attended, and satisfaction with MBSR). Additionally, pre and post questionnaires will assess readiness to quit, stress level, and satisfaction with and acceptability of MBSR after every cohort). The primary outcome is engagement in smoking cessation treatment which includes counseling and/or pharmacotherapy. Additionally, the investigators will hold a focus group after each of the 3 cohorts have completed the program to discuss acceptability of study materials as well as facilitators and barriers to participation in the training. Data collected from this study will generate preliminary data to successfully justify and secure future funding for a larger controlled study.

Interventions

Participants will take part in a 9-week Smoking Cessation Program

Sponsors

Boston Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age 18 or older * smoked cigarettes in the past week * cancer diagnosis more than 6 months * have a scheduled visit in the oncology clinic with an oncologist or mid-level provider * telephone access * English speaking for screening/consenting purposes * able and willing to participate in the study protocol and provide informed consent

Exclusion criteria

* cancer prognosis less than 6 months * planning to move out of the area within 6 months * actively using evidence-based smoking cessation treatment during screening * pregnant women and women planning on becoming pregnant

Design outcomes

Primary

MeasureTime frameDescription
Number of participants engaged in smoking cessation counseling3 monthsParticipants will complete a weekly intake form and a telephone based questionnaire at 3 months to assess engagement in evidence based smoking cessation counseling by completion of one of the following: (a) at least 1 visit with Boston Medical Center pulmonary smoking cessation program for individual quit plan, or (b) at least 1 telephone based Quitworks counseling session, or (c) \>1 PCP or Oncology visit in which smoking cessation treatment is discussed.

Secondary

MeasureTime frameDescription
Number of patients with reduced stress assessed using validated Perceived Stress Scale (PSS)3 monthsStress reduction will be assessed using validated Perceived Stress Scale (PSS)
Number of patients reporting readiness to quit smoking based on the Transtheoretical Model and Stages of Change3 monthsPatient self report of readiness to quit smoking based on stage of change: precontemplation, contemplation, preparation or action assessed on questionnaire at baseline, 9 weeks, and at 3 month follow up
Number of participants identifying a smoking quit date3 monthsParticipant will report if quit date has been determined on weekly questionnaire and/or at three month follow up
Number of participants reporting 7 day smoking abstinence from cigarettes3 monthsParticipant will report 7 day smoking abstinence from cigarettes on weekly questionnaire and/or at three month follow up

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026